Articles by Abby Proch
-
Working (Well) With Patient Advocates: The Sponsor POV
1/12/2026
Aeovian CEO Allison Hulme reflects on Aeovian Pharmaceuticals' partnership with the TSC Alliance and how it’s informed research and development of their first-in-class selective mTORC1 inhibitor.
-
Working (Successfully) With Pharma: A PAG's Perspective
1/12/2026
TSC Alliance President and CEO Kari Rosbeck details the patient advocacy group's unique and fruitful relationship with Aeovian Pharmaceuticals in developing the company's first-in-class selective mTORC1 inhibitor for TSC-related refractory epilepsy.
-
How Should Scientific Focus Change In 2026? Researchers Weigh In
1/8/2026
To kick off 2026, clinical researchers share how they think research should change in the new year.
-
Researchers Want A Design Shake-Up In 2026
1/7/2026
When asked what clinical research professionals should leave behind in 2025, quite a few lamented the stale, even problematic, approach to clinical trial design. Here's what they want done differently in 2026.
-
No Surprise Here: Experts Value Clinical Relevance Over Statistical Relevance
12/31/2025
Experts weighed in: “Agree or disagree? Statistical significance is preferable to clinical relevance.”
-
Trial Matching, Source Data, And More: How Clinical Researchers Used AI In 2025
12/30/2025
Researchers reflect on the past year and share how they used AI for clinical research in 2025.
-
What Can We Expect From The FDA In 2026?
10/20/2025
Expert panelists at the 2025 RAPS Convergence discussed what lies ahead for the FDA in 2026.
-
Diverse Enrollment — Ahem, "Biological Variability" — Gets Widespread Support At RAPS Convergence
10/16/2025
DEI, diverse enrollment, biological variability -- whatever you call it, industry leaders at RAPS Convergence discussed their unwavering support of it when it comes to executing clinical trials that align "good science" with "the right thing to do."
-
What Sites Wish Tech Vendors (And Sponsors) Heard At SCDM But Probably Didn't
10/8/2025
During a Society for Clinical Data Management (SCDM) panel discussion, three site-side representatives discussed the challenges clinical research coordinators have executing their clinical duties amid increasingly complex data entry demands.
-
SCDM 2025: Practical Advice From Global Regulators — Including The FDA
10/6/2025
Discover what regulators from around the world, including the FDA, think should be top of mind for clinical data managers.